Filgrastim in Treating Patients With Bortezomib- or Carfilzomib-Refractory Multiple Myeloma
This study is currently recruiting participants.
Verified May 2013 by Washington University School of Medicine
Sponsor:
Washington University School of Medicine
Information provided by (Responsible Party):
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT01537861
First received: February 15, 2012
Last updated: May 6, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | June 2014 |
| Estimated Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |